- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Bioscience
Roche acquires Marcadia Biotech
December 30, 2010
Chris O'MalleyMarcadia Biotech Inc., a Carmel-based biopharmaceutical company founded by prominent scientists from Eli Lilly and Co. in
2006, has been acquired by Swiss life sciences giant Roche.
MoreDow AgroSciences moves into new research facility
November 20, 2010
IBJ StaffThe division of Dow Chemical has a 15-year lease with Indianapolis-based developer Browning Investments on the two-story building
near West 96th Street.
MoreDow Agro acquires Colorado seed company
September 2, 2010
IBJ StaffGrand Valley Hybrids has been growing and conditioning hybrid seed corn in the West since 1946.
MoreLocal economic espionage case full of intrigue
September 1, 2010
Cory SchoutenThe government's allegations read like a spy novel: Dr. Ke-xue "John" Huang lands a job at Indianapolis-based
Dow AgroSciences and over five years works himself into a position of trust, with access to trade secrets and processes the
company has invested $300 million to develop.
MoreEx-Dow Agro scientist's espionage indictment unsealed
August 31, 2010
IBJ StaffA federal indictment unsealed Tuesday in Indianapolis charged 45-year-old Ke-xue "John" Huang
with theft and attempted
theft of trade secrets to benefit a foreign government.
MoreEx-Dow AgroSciences employee accused of stealing trade secrets
July 31, 2010
Chris O'MalleyThe U.S. Department of Justice has charged Ke-xue Huang, a native of China's Hunan province, of stealing trade secrets of
a Dow AgroSciences insecticide and giving them to the People's Republic of China. Federal agents arrested the former Dow Agro
scientist July 13 in Westboro, Mass.
MoreIndiana life sciences companies capture more venture capital money in first half of 2010
July 31, 2010
IBJ StaffVenture dollars for Hoosier companies are still few, but the flow of deals is picking up.
MoreAIT Labs moving headquarters, adding 160 jobs
June 17, 2010
Scott OlsonThe Indianapolis-based forensics, clinical and pharmaceutical testing firm, led by CEO Michael Evans, plans to invest $74
million to acquire and equip
an existing 90,000-square-foot building in Woodland Corporate Park near West 79th Street and Interstate 465.
MoreMedical device startup FlowCo enlists Guidant alums
April 24, 2010
Chris O'MalleyThe upstart developer of a device to help doctors choose the right-sized stent to prop open clog-prone arteries has brought
aboard former Guidant Corp. executives, including Bill McConnell. Their regulatory and marketing expertise could help FlowCo
Inc. bring its artery-measurement
product to market as soon as 2011.
MoreIndiana companies that serve pharmaceutical industry grew in 2009
February 20, 2010
IBJ StaffThe firms continued to grow over the last year but face increasing challenges, according to a new report by Indianapolis-based
life sciences trade group BioCrossroads.
MoreBuilder looks to cold storage for steady work in a weak economy
December 5, 2009
Brock BenefielCold storage might become a hot business for a building contractor.
MoreLilly Endowment funds OrthoWorx effort with $7 million
September 23, 2009
J.K. WallA new group expected to develop the orthopedic implants industry in Warsaw will be able to proceed now that Indianapolis-based
Lilly Endowment Inc. is putting $7 million behind it, according to an announcement this morning.
MoreMedical device developer receives $1M in federal funding
September 10, 2009
Scott OlsonIndianapolis-based FAST Diagnostics, a developer of a method to quickly measure kidney function, announced today that it has
received $1 million in federal funding.
MoreAbatement approval paves way for Covance jobs
August 12, 2009
Scott OlsonThe Hancock County Council this morning unanimously approved a tax-incentive agreement that should lead Covance Inc. to add
315 jobs at its Greenfield Laboratories.
MoreEmerging life sciences companies grabbing more in government grants
August 10, 2009
Chris O'MalleyMore emerging life science companies have found life in the form of federal
Small Business Innovation Research grants.
MoreLilly cancels trials for experimental MS drug
July 28, 2009
J.K. WallEli Lilly and Co. and a development partner has canceled clinical trials on an experimental drug to treat multiple sclerosis
after the drug failed to delay progression of the disease in trial patients.
MoreDow Agrosciences introduces genetically modified corn seed
July 27, 2009
IBJ StaffEven after a string of acquisitions, Dow AgroSciences is a bit player in the seed business. But the new genetically
modified corn it developed with St. Louis-based giant Monsanto Co. finally provides the breakthrough product that could grow
its seed sales substantially.
MoreStem cell discovery promises health care revolution
April 13, 2009
Bloomberg NewsScientists are using a new stem-cell technique that may someday revolutionize care for disorders as diverse as diabetes, Alzheimer's
disease and muscular dystrophy.
MoreIndiana playing trailblazing role in drive to tailor pharmaceuticals to genetic makeup of individuals
April 13, 2009
Chris O'MalleyIndiana is becoming not only a hotbed of "pharmacogenomics" research, but also a trailblazer in finding practical ways to
use it on the practitioner level.
MoreExecutives make many trips to Washington to argue for 14 years of sales exclusivity for new drugs made from cells
March 23, 2009
J.K. WallEli Lilly & Co. executives are making many trips to Washington to argue for 14 years of sales exclusivity for new drugs made
from cells.
MoreBiotech push may help offset generic competition; some analysts skeptical
February 2, 2009
J.K. WallLilly executives want to make biotech their top focus.
MoreBiotech venture fund in works
January 5, 2009
Peter SchnitzlerBioCrossroads is setting the stage to create Indiana Future Fund II, an effort that would raise tens of millions of dollars
for speculation on promising Hoosier life science companies.
MoreReport sees jackpot with BioCrossroads, but expert sees obstacles
February 4, 2008
J.K. WallThree months after launching an initiative to boost drug-development firms in Indiana, officials at BioCrossroads have written
a report that attempts to show in detail the vast market opportunity they see.
MoreIU takes statewide approach to life sciences pitch
January 21, 2008
J.K. WallFor the last two months, two academics at Indiana University and Purdue University have been discussing how the institutions
can work together to rev up research in medicine and life sciences and, in the process, boost Indiana's economy.
MoreEx-Lilly execs take on diabetes with Carmel startup
November 6, 2006
Peter SchnitzlerFour former top scientists at Eli Lilly and Co. have formed a Carmel-based company to develop diabetes therapies--a venture
observers say has the potential to become the kind of blockbuster success BioCrossroads was built to stimulate.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
It's also across the street from Fogo de Chao and Morton's....
Yep, the haters are trying to make good news bad. I guess it is hard to get people to believe the series is dying when they are gaining new sponsors.
David Copperfield! I remember watching his specials on TV when I was little.
Don't forget this is next to an MMA gym, a pawn shop, and some abandoned spaces.
Good project for Zionsville - A group who has owned the property for many years has waited and worked patiently to bring highest and best use development to a major corridor, and mix that in with the great downtown you have. Win Win. All the Best to Pittman Partners and Zionsville.